Vitrolife AB (publ)
VTRLY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.37B
Close$
$3.53
65.5% downside
Current Fair Value
65.5% downsideOvervalued by 65.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.37 Billion |
|---|---|
| Enterprise Value | $2.18 Billion |
| Annual dividend | $0.12 |
| Dividend yield | 1.01% |
| Earnings per Share | $-34.79 |
| Beta | 1.71 |
| Outstanding Shares | 134,086,364 |
Return
| Return on Equity | -60.97% |
|---|---|
| Return on Assets | -43.88% |
| Return on Invested Capital | -44.40% |
Valuation & Multiples
| P/E Ratio | -2.97 |
|---|---|
| PEG | -12.64 |
| Price to Sales | 0.41 |
| Price to Book Ratio | 0.17 |
| Enterprise Value to Revenue | 0.64 |
| Enterprise Value to EBIT | -0.46 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.75 |
| Debt to Equity | 0.2 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Vitrolife AB
1,151 employees
CEO: Bronwyn Brophy O'Connor
Vitrolife AB (publ) engages in development, production, and marketing of products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labwar...